Australia's most trusted
source of pharma news
Posted 21 December 2021 PM
Vaxine has become the first Aussie biotech to receive a provisional determination for a Covid vaccine from the TGA, an important step made possible thanks to a crowd funding initiative.
Sharen Petrovsky, Vaxine's business manager, set up the GoFundMe page called, 'Bring Covax-19 Vaccine back to Australia' in October to cover the expensive process of applying for registration in Australia with the TGA.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.